Short-term results of intravitreal dexamethasone implant (OZURDEX®) in treatment of recalcitrant diabetic macular edema: A case series
Context: Dexamethasone Posterior-Segment Drug Delivery System is a novel, biodegradable, sustained-release drug delivery system (OZURDEX® ) for treatment of macular edema following retinal vein occlusion and posterior uveitis. However, its potential role in management of diabetic macular edema has n...
Main Authors: | Pukhraj Rishi, Ekta Rishi, Lakshmi Kuniyal, Gaurav Mathur |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Oman Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ojoonline.org/article.asp?issn=0974-620X;year=2012;volume=5;issue=2;spage=79;epage=82;aulast=Rishi |
Similar Items
-
Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema
by: Rishi, Pukhraj, et al.
Published: (2020-04-01) -
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
by: Jazmín Baca Moreno, et al.
Published: (2024-03-01) -
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
by: Verónica Castro-Navarro, et al.
Published: (2019-01-01) -
Short-term efficacy of intravitreal dexamethasone implant in vitrectomized eyes with recalcitrant diabetic macular edema and prior anti-VEGF therapy
by: Ankoor R Shah, et al.
Published: (2016-01-01) -
Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
by: Saud M Aljohani, et al.
Published: (2021-01-01)